AI TRADING

AI Robots

MOST POPULAR

Stocks & ETFs, MFs & FOREX

AI Real Time Patterns

Forex

Patterns (one at a time)

Stocks & ETFs & FOREX

INVESTING

CREATE & TRACK

AI Portfolio Wizards for Beginners

Stocks & ETFs, MFs & FOREX

AI Portfolio Manager

Stocks & ETFs, MFs & FOREX

DISCOVER & FOLLOW

401(k) Portfolios & Reports

Paper Trades Exchange

COMMUNITY

Find your way Market Summary Dashboard What`s new AI Robots 1-on-1 lessons Help Sale

SABS

TRADE

AS OF

Apr 26 closing price

Price

$4.20

Change

+$0.06 (+1.45%)

Capitalization

39.21M

12 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SABS is expected to report earnings to rise+16.67% to -83 cents per share on March 28

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

03/27/24

SABS - SAB Biotherapeutics

Q4'23

Est.

$-0.83

Q3'23

Missed

by $0.88

Q2'23

Est.

$-0.14

Q1'23

Missed

by $0.04

Q4'22

Missed

by $0.08

The last earnings report on September 30 showed earnings per share of -100 cents, missing the estimate of -12 cents. P/B Ratio (2.521) is normal, around the industry mean (26.918). P/E Ratio (9.709) is within average values for comparable stocks, (126.398). SABS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.211). Dividend Yield (0.000) settles around the average of (0.029) among similar stocks. P/S Ratio (2.959) is also within normal values, averaging (443.914). With 20.44K shares outstanding, the current market capitalization sits at 38.47M.

View a ticker or compare two or three

Compare

SABS